Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000997165 | SCV001152349 | likely pathogenic | not provided | 2017-04-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001858855 | SCV002247206 | pathogenic | Alstrom syndrome | 2021-08-04 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 808770). This premature translational stop signal has been observed in individual(s) with Alstrom syndrome (PMID: 25846608). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Leu543*) in the ALMS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ALMS1 are known to be pathogenic (PMID: 17594715). |
Fulgent Genetics, |
RCV001858855 | SCV002808266 | likely pathogenic | Alstrom syndrome | 2022-01-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000997165 | SCV005442953 | pathogenic | not provided | 2024-07-03 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25846608, 32531858) |